Fundamental Analysis of Utah Medical Products Inc - Growth / Value Index
UTMD - Valuation Highlights
Valuation Analysis
Book Value in last 3 years is trending up
Tsr Value Index - Very Poor Score of 18.75
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 15.46 | 15.00 | 21.45 % | |
| Price to Book | 2.04 | 1.98 | -11.52 % | 1.97 |
| Price to Sales | 5.16 | 4.93 | 0.947 % | |
| Enterprise Value to EBITDA Multiple | 18.00 | 14.45 | 65.64 % |
UTMD - Profitability Highlights
Profitability Analysis
Piotroski F Score - Good Value of 7.0
Earning Yield of 6.58 %
Excellent Net Margin for last 3 years
Company Earning excess return
During the past twelve months, the company has given a strong Net Margin of 33.39%
All key Trailing Twelve Months Margin growing by 15 %
Good Return On Capital Employed of 13.17
Good Return on Equity of 13.22% is achieved by the company
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 13.22 | 13.17 | -27.14 % | 3.10 |
| Return On Asset | 12.40 | 12.48 | -25.17 % | 2.92 |
| Net Profit Margin | 33.39 | 32.85 | -16.88 % | 34.89 |
| Operating Profit Margin | 33.07 | 34.79 | -8.10 % | 34.24 |
| EBITDA Margin | 38.39 | 46.60 | 17.94 % | 48.16 |
Highlights
| Market Cap | 246002 K |
| Enterprise Value | 338918 K |
| Price/Book TTM | 2.04 |
| Outstanding Share | 3528.43 K |
| Float/ Outstanding Share | 86.78% |
| Dividend Yield | 1.70 % |
Share Holding
Guru Numbers
| Price/Graham No | 1.17 |
| Peter Lynch Ratio | -1.14 |
| Piotroski F Score | 7.00 |
| Altman Z Score | 23.80 |
| Sloan Ratio | -0.0423 |
| Peter Lynch Fair Value | 0 |
UTMD - Growth Highlights
Growth Analysis
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Poor Score of 22.71
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 49044.00 K | 1.56 % | 8.05 % |
| Gross Profit | 28094.00 K | 2.89 % | 8.60 % |
| EBITDA | 18825.75 K | 16.09 % | 9.89 % |
| Net Profit | 16378.00 K | 18.18 % | 7.72 % |
| EPS | 4.51 | 17.66 % | NA |
UTMD - Stability Highlights
Stability Analysis
Tsr Stability Index - Excellent Score of 95.00
Altman Z Score of 23.77 suggests good Stability
Debt to equity ratio has decreased and is lowest in last three years
Cash ratio of 20.00
Company financial liquidity has improved
Interest Coverage of 0
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.0004 | -22.50 % | 0.0004 |
| Cash Ratio | 20.00 | 53.32 % | |
| Quick Ratio | 20.82 | 47.71 % | 17.89 |
| Shareholders Equity | 94.73 | 2.70 % | |
| Debt to EBITDA | 0.0020 | -25.03 % |
Historical Valuation Ratios of Utah Medical Products Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Utah Medical Products Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Utah Medical Products Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Utah Medical Products Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)